Cosmos Health (COSM) announced the commencement of its U.S. operations with the launch of its proprietary Sky Premium Life food supplements brand. All Sky Premium Life products sold in the United States are manufactured locally in GMP-certified, FDA-registered, and UL-audited U.S. facilities, underscoring the Company’s commitment to regulatory excellence and product integrity while mitigating tariff exposure and cross-border logistical risks. Sales are already underway for Sky Premium Life NOOR Collagen, a proprietary product formulated with premium marine collagen tripeptide, currently available in capsule form and featuring a clinically validated formula designed to support skin and joint health. The Company anticipates strong gross margins of approximately 75% and significant cash flow generation from its Sky Premium Life U.S. operations. NOOR Collagen alone is projected to generate more than $12 million in annualized revenue, with additional growth expected as the Company introduces new products and expands its Sky Premium Life portfolio in the U.S. to meet strong consumer demand.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on COSM:
- Cosmos Health files to sell 78.64M shares of common stock for holders
- Cosmos Health’s Sky Pharma sign distribution agreement with Scientific Pharmacy
- Cosmos makes initial $1M ethereum purchase under digital asset treasury strategy
- Cosmos Holdings Secures $8M Convertible Note Agreement
- Cosmos Health secures $300M financing facility to launch Ethereum strategy